Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Pesavento

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of the American Society of Nephrology : JASN|March 15, 2014
BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trialMyra A Carpenter, Alin John, Matthew R Weir, et al.
Annals of Hepatology|January 30, 2021
Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysisLindsay A Sobotka, Khalid Mumtaz, Michael R Wellner, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 1, 2022
Survey of Salary and Job Satisfaction of Transplant Nephrologists in the United StatesNeeraj Singh, Mona D Doshi, Jesse D Schold, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2018
Impact of Navigators on First Visit to a Transplant Center, Waitlisting, and Kidney Transplantation: A Randomized, Controlled TrialCatherine M Sullivan, Kitty V Barnswell, Kate Greenway, et al.
Circulation|April 13, 2011
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trialAndrew G Bostom, Myra A Carpenter, John W Kusek, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of the American Society of Nephrology : JASN|March 15, 2014
BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trialMyra A Carpenter, Alin John, Matthew R Weir, et al.
Annals of Hepatology|January 30, 2021
Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysisLindsay A Sobotka, Khalid Mumtaz, Michael R Wellner, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 1, 2022
Survey of Salary and Job Satisfaction of Transplant Nephrologists in the United StatesNeeraj Singh, Mona D Doshi, Jesse D Schold, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2018
Impact of Navigators on First Visit to a Transplant Center, Waitlisting, and Kidney Transplantation: A Randomized, Controlled TrialCatherine M Sullivan, Kitty V Barnswell, Kate Greenway, et al.
Circulation|April 13, 2011
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trialAndrew G Bostom, Myra A Carpenter, John W Kusek, et al.
Pageof 3